|
6.12.2017 |
EN |
Official Journal of the European Union |
C 417/98 |
REPORT
on the annual accounts of the European Chemicals Agency for the financial year 2016, together with the Agency’s reply
(2017/C 417/15)
INTRODUCTION
|
1. |
The European Chemicals Agency (hereinafter ‘the Agency’, aka ‘ECHA’), which is located in Helsinki, was set up by Regulation (EC) No 1907/2006 of the European Parliament and of the Council (1). Its main tasks are to ensure a high level of protection of human health and the environment as well as the free movement of substances on the internal market while enhancing competitiveness and innovation. The Agency also promotes the development of alternative methods for the assessment of hazards relating to substances. |
|
2. |
The table presents key figures for the Agency (2). Table Key figures for the Agency
|
|||||||||||||
INFORMATION IN SUPPORT OF THE STATEMENT OF ASSURANCE
|
3. |
The audit approach taken by the Court comprises analytical audit procedures, direct testing of transactions and an assessment of key controls of the Agency’s supervisory and control systems. This is supplemented by evidence provided by the work of other auditors and an analysis of management representations. |
|
OPINION
Reliability of the accounts Opinion on the reliability of the accounts
Legality and regularity of the transactions underlying the accounts Revenue Opinion on the legality and regularity of revenue underlying the accounts
Payments Opinion on the legality and regularity of payments underlying the accounts
Responsibilities of management and those charged with governance
Auditor’s responsibilities for the audit of the accounts and underlying transactions
Other matter
|
|
17. |
The comments which follow do not call the Court’s opinion into question. |
COMMENTS ON BUDGETARY MANAGEMENT
|
18. |
Carry-overs of committed appropriations remained high for Title III (REACH operational expenditure) at 10,1 million euro, i.e. 39 % (2015: 7,3 million euro, i.e. 32 %) and are even higher for Title IV (Biocides operational expenditure) at 1,3 million euro, i.e. 68 % (2015: 1,5 million euro, i.e. 74 %). Such high level of carry-overs is in contradiction with the budgetary principle of annuality. The Agency may consider increasing the use of differentiated budget appropriations to better reflect the multiannual nature of operations and unavoidable delays between the signature of contracts, deliveries and payments. |
COMMENTS ON INTERNAL CONTROL
|
19. |
Under the Biocidal Products Regulation, ECHA contributes to the functioning of the market for biocidal substances and products. In its audit report dated November 2016 the Commission’s Internal Audit Service (IAS) concluded that the design and practical implementation of the internal control system in ECHA in relation to the Agency’s processes and activities under the Biocidal Product Regulation is effective and efficient. Although no major weaknesses were identified, the IAS identified some scope for further improvement. The Agency and IAS agreed on a plan to take corrective action. |
OTHER COMMENTS
|
20. |
Different from most other agencies, ECHA’s founding regulation does not explicitly require periodical external evaluations of its activities, which are key elements to assess performance. |
FOLLOW-UP OF PREVIOUS YEARS’ COMMENTS
|
21. |
An overview of the corrective action taken in response to the Court’s comments from previous years is provided in the Annex. |
This Report was adopted by Chamber IV, headed by Mr Baudilio TOMÉ MUGURUZA, Member of the Court of Auditors, in Luxembourg at its meeting of 12 September 2017.
For the Court of Auditors
Klaus-Heiner LEHNE
President
(1) OJ L 396, 30.12.2006, p. 1.
(2) More information on the Agency’s competences and activities is available on its website: www.echa.europa.eu
(3) Budget figures are based on payment appropriations.
(4) Staff includes officials, temporary and contract staff and seconded national experts.
Source: data provided by the Agency.
(5) The financial statements comprise the balance sheet, the statement of financial performance, the cash flow statement, the statement of changes in net assets and a summary of significant accounting policies and other explanatory notes.
(6) The reports on implementation of the budget comprise the reports which aggregate all budgetary operations and the explanatory notes.
(7) Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council (OJ L 298, 26.10.2012, p. 1).
ANNEX
Follow-up of previous years’ comments
|
Year |
Court's comment |
Status of corrective action (Completed/Ongoing/Outstanding/N/A) |
|
2014 |
The expenditure for procedures associated with one new specific activity of the Agency, the implementation of the Regulation concerning biocidal products, was to be, in principle, covered by application fees for the registration of these products. However, fees collected in 2014 covered only 17 % of this expenditure and the remaining part was in fact financed by contributions to the Agency’s budget from the Union (6,3 million euro) and EFTA countries (0,2 million euro) (1). |
Ongoing |
|
2015 |
The Agency pays 50 % of the cost for after-school care of staff children in the European School in Helsinki. Its contribution is limited to 1 000 euro per child per annum and in total amounted to some 95 000 euro in 2015. This measure of a social nature was approved in 2008 by the Agency’s Director but has not been communicated to the budgetary authority in the framework of the budget procedure (2). |
Completed |
|
2015 |
Carry-overs of committed appropriations were high for Title IV (Biocides operating expenditure) at 1,5 million euro, i.e. 74 %. They mainly concern a large-scale IT project (1,4 million euro). This project could only be started in the second half of 2015 when sufficient fee income for its funding had been collected. |
N/A |
(1) Fees collected in 2015 covered 62 % of this expenditure.
(2) Article 1e of Regulation No 31 (EEC), 11 (EAEC), laying down the Staff Regulations of Officials and the Conditions of Employment of Other Servants of the European Economic Community and the European Atomic Energy Community (OJ 45, 14.6.1962, p. 1385/62).
THE AGENCY’S REPLY
|
19. |
The highest carry-over amounts stem from multiannual IT development projects and rapporteur contracts for substance evaluation which entail a statutory 12-month period starting from the adoption of the Community rolling action plan in March. For the latter, the Agency has already created a differentiated budget line for 2017, which will reduce the nominal carry-over rate for 2017 and beyond. For IT expenditure, ECHA will also consider the possibility of using differentiated budget lines going forward. |
|
20. |
Noted. |
|
21. |
ECHA’s founding regulation scheduled a first external evaluation of the Agency for 2012, see Article 75(2). The Commission duly undertook this review with the support of an external contractor (PwC). Although not explicitly required by ECHA’s founding regulation, in accordance with the Better Regulation EU Evaluation Guidelines, the Commission commissioned another external ECHA performance evaluation study (Deloitte and VVA) in 2016. The consultants’ report is available here: https://ec.europa.eu/growth/sectors/chemicals/reach_en As soon as the Commission adopts its own report on the REACH review in 2017, appropriate follow-up actions will be put in place by ECHA to address the recommendations stemming from the formal Commission’s report. |